BioPharma APAC

Countries North America

WuXi Biologics Topped Off the Steel on its Commercial Biomanufacturing Facility

WuXi Biologics ("WuXi Bio") (2269.HK), a global Contract Research, Development and Manufacturing Organization (CRDMO), held a topping-off ceremony, i...

September 29, 2022 | News

WuXi Biologics Announces GMP Release of Its First North American Biomanufacturing Facility

The site's clinical manufacturing operations have an initial capacity of 4,000L and will grow to 6,000L, utilizing only single-use technology, adding to th...

September 01, 2022 | News

Thermo Fisher Scientific Expands Viral Vector Manufacturing Capabilities

Thermo Fisher Scientific, the world leader in serving science, today expanded its cell and gene therapy capabilities with the opening of its new previ...

August 24, 2022 | News

Thermo Fisher's $76 million investment expands cell culture media production

To meet increasing global demand for cell culture media used in the manufacturing of new vaccines and biologics, Thermo Fisher Scientific has expanded its ...

August 04, 2022 | News

Merck Breaks Ground on Company’s First Lateral Flow Membrane Production Facility

New facility to manufacture the company’s Hi-Flow™ Plus lateral flow membrane used in rapid diagnostic test kit manufacturing, including Covi...

July 18, 2022 | News

ACTO Secures $18M Financing to Accelerate Growth and Strengthen Position as #1 Learning Platform in Life Sciences

The investment was led by Questa Capital, a healthcare venture growth equity firm that actively invests in healthcare and life sciences software. With...

July 18, 2022 | News

miR Scientific announce the commercial availability of the miR Sentinel™ Prostate Cancer Test

miR Sentinel™ is a novel, urine-based, molecular test that analyzes small non-coding RNA using a proprietary biostatistical algorithm. The miR Sentin...

July 14, 2022 | News

Discovery Life Sciences acquires AllCells

Discovery Life Sciences™ (Discovery), the biospecimens and biomarkers™ specialists, today announced the acquisition of AllCells, a l...

July 13, 2022 | News

U.S. Government Secures 3.2 Million Doses of Novavax COVID-19 Vaccine

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious dise...

July 12, 2022 | News

Despite Supreme Court Ruling, Abortion Remains Legal In Dc, Maryland, And Virginia

Despite the Court's failure to defend this fundamental freedom, abortion is still legal in DC, Maryland, and Virginia and Planned Parenthood...

June 27, 2022 | News

Merck Opens €59 Million CDMO Facility to Address Demand for Critical Cancer Therapies

Expansion doubles production of the most highly potent active pharmaceutical ingredients (HPAPIs) Merck now one of industry’s largest manufacturer...

June 24, 2022 | News

The 3rd BIO International Convention 2022 is Approaching

Neurophth Therapeutics is a leading clinical-stage gene therapy company with robust ophthalmic pipeline. With subsidiaries in China and USA,...

June 09, 2022 | News

Novotech Sponsors Pre-ASCO China Summit Panels on Early Phase Oncology Trials, Regulatory Strategy for China and US

The Pre-ASCO Live Zoom series was watched by more than 20,000 people globally. The Novotech-sponsored panels, China CST 9:00-10:30 AM (May 14); US EST 9:00...

June 03, 2022 | News

GenScript Launches GMP Single-Strand and Double-Strand DNA Service for Supporting Gene and Cell Therapy Development

GenScript USA Inc., the world's leading life-science research tools and services provider, announced the availability of new GMP-grade ...

May 17, 2022 | News

Stay Connected